Loading Events

« All Events

Tentative Covid Vaccine Event

January 6, 2023

Summary of recent changes (last updated September 2, 2022):
  • New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group
  • Recommendations for use of a bivalent Moderna booster dose in people ages 18 years and older
  • Recommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 12 years and older
  • Updated guidance for observation periods following COVID-19 vaccination
  • Updated guidance on COVID-19 vaccination and multisystem inflammatory syndrome (MIS) in children (MIS-C) and in adults (MIS-A)

Details

Date:
January 6, 2023